US20040220659A1 - Stent covering formed of porous polytetraflouroethylene - Google Patents
Stent covering formed of porous polytetraflouroethylene Download PDFInfo
- Publication number
- US20040220659A1 US20040220659A1 US10/858,589 US85858904A US2004220659A1 US 20040220659 A1 US20040220659 A1 US 20040220659A1 US 85858904 A US85858904 A US 85858904A US 2004220659 A1 US2004220659 A1 US 2004220659A1
- Authority
- US
- United States
- Prior art keywords
- stent
- siloxane
- porous
- cover
- ptfe
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
- A61F2/90—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
- A61F2/91—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
- A61F2/90—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
- A61F2/91—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
- A61F2/915—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/04—Macromolecular materials
- A61L31/048—Macromolecular materials obtained by reactions only involving carbon-to-carbon unsaturated bonds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L31/146—Porous materials, e.g. foams or sponges
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
- B29C—SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
- B29C67/00—Shaping techniques not covered by groups B29C39/00 - B29C65/00, B29C70/00 or B29C73/00
- B29C67/20—Shaping techniques not covered by groups B29C39/00 - B29C65/00, B29C70/00 or B29C73/00 for porous or cellular articles, e.g. of foam plastics, coarse-pored
- B29C67/202—Shaping techniques not covered by groups B29C39/00 - B29C65/00, B29C70/00 or B29C73/00 for porous or cellular articles, e.g. of foam plastics, coarse-pored comprising elimination of a solid or a liquid ingredient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
- A61F2/90—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
- A61F2/91—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
- A61F2/915—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
- A61F2002/91533—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other characterised by the phase between adjacent bands
- A61F2002/91541—Adjacent bands are arranged out of phase
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2220/00—Fixations or connections for prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2220/0025—Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements
- A61F2220/005—Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements using adhesives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2220/00—Fixations or connections for prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2220/0025—Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements
- A61F2220/0058—Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements soldered or brazed or welded
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2220/00—Fixations or connections for prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2220/0025—Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements
- A61F2220/0066—Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements stapled
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2220/00—Fixations or connections for prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2220/0025—Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements
- A61F2220/0075—Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements sutured, ligatured or stitched, retained or tied with a rope, string, thread, wire or cable
Definitions
- the present invention relates to an endoprosthesis device or intraluminal device, in particular a stent, having a covering comprising porous polytetrafluoroethylene formed by removing the siloxane from an interpenetrating network of polytetrafluoroethylene and siloxane, and to a method of making the endoprosthesis device.
- the stent covering can be applied on the exterior surface of the stent, on the interior surface of the stent, or both, at a thickness of as low as about 15 microns.
- Endoprosthesis devices including stents, stent-grafts, grafts, vena cava filters, balloon catheters, and so forth, are placed or implanted within various body vessels for the treatment of various diseases.
- One particular type of an endoprosthesis device is the stent.
- a stent is implanted within a vessel for the treatment of stenoses, strictures, or aneurysms in the blood vessels.
- the devices are implanted within the vascular system to reinforce diseased, partially occluded, weakened or abnormally dilated sections of the blood vessel.
- Stents are often employed after angioplasty to prevent restenosis of a diseased blood vessel. While stents are most notably used in blood vessels, they have also been implanted in other bodily vessels including urinary tracts and bile ducts to reinforce and prevent neoplastic growth.
- Stents are typically longitudinal tubular devices formed of biocompatible materials and come in a variety of construction types, and are often expandable in nature. Many if not all of the materials used for stents involve metal or carbon fiber materials which are highly electro-positive and are bio-active. Since stents tend to be used under conditions were they are counteracting disease processes, supporting healing processes, or guarding against stenosis of a passage, bio-activity, which may encourage undesirable or poorly regulated growth processes, or lead to clot formation, should be avoided.
- Coating of the stent can keep the stent from directly contacting surrounding tissue or fluids, and thus can theoretically protect against unwanted electrochemically induced tissue reactions.
- One approach to this drawback is to provide a coating, liner, cover or both, for the stent which prevents the healing or diseased layer of tissue from directly contacting the stent, or from passing through the stent in any way.
- Such liners may be formed, for example, of porous polytetrafluoroethylene (PTFE) which allows the passage of fluids and vital materials while serving as a barrier to tissue growth.
- PTFE porous polytetrafluoroethylene
- a further difficulty which may arise is that the layer or sleeve of polymer must be attached to the stent for example, by staples or sutures at one end, or is prone to developing loose pockets or folds which might accumulate organic matter or lead to sepsis or unusual growth.
- the necessarily thin liner material may detach or degrade.
- the risk of loose or unattached liner material is particularly great for constructions which utilize poorly adherent polymers, such as PTFE, or structures which seek to combine an expandable stent of stiff material, which changes both its dimension and its shape, with a dissimilar liner or shell.
- a metallic expandable stent includes an outer covering of ePTFE.
- the ePTFE cover exhibits suitable expansion capabilities so as to enable the cover to expand upon expansion of the underlying stent.
- a polytetrafluoroethylene/lubricant blend may be extruded into a tube and the tube heated to remove the lubricant.
- the ePTFE in order to impart the expandable characteristics to the ePTFE cover during formation of the ePTFE cover material, the ePTFE must undergo successive processing steps of expanding the material, sintering the material, radially dilating the material and resintering the dilated material, a procedure that is quite process intensive.
- the device described therefore requires precise manufacturing techniques and is extremely processing sensitive. Careful processing of the material forming the cover is required in order for the cover to exhibit sufficient expansion capabilities.
- U.S. Pat. No. 5,824,046 describes a composite intraluminal device, in particular an elongate radially expandable tubular stent having an interior luminal surface and an opposed exterior surface extending along a longitudinal stent axis.
- a stent cover is formed of unsintered ePTFE which is expandable.
- the present invention relates to a method of forming porous polytetrafluoroethylene (PTFE) without having to stretch or expand the material, and to a radially expandable endoprosthesis device covered with the solid but expandable polymer covering comprising the porous PTFE material obtained using the method of the present invention.
- the porous PTFE covering physically isolates the endoprosthesis from surrounding blood and tissue.
- the porous PTFE is prepared by extracting siloxane from an interpenetrating network (IPN) of PTFE and siloxane, leaving behind a porous PTFE structure without having to expand and stretch the PTFE. Consequently, the PTFE material used in the endoprosthesis device coverings of the present invention is not expanded PTFE, but it is porous.
- IPN interpenetrating network
- the end of the prosthesis device of the present invention includes an elongate radially expandable tubular stent having an interior surface and in exterior surface extending along a longitudinal stent access.
- the expandable tubular stent has a stent cover on said interior surface, exterior surface or both, the cover being formed of a porous polytetrafluoroethylene.
- the porous polytetraflouroethylene cover is a non-stretched porous structure, the non-stretched structure lacking note and viable structure.
- the present invention relates to a radially expandable stent for use in treating stenoses wherein the stent is covered with an expandable polymer covering comprising the porous PTFE prepared according to the present invention that physically isolates the stent from surrounding blood and tissue.
- FIG. 1 is a perspective view of one type of intraluminal device that may be used in the present invention.
- FIG. 2 is a perspective view of a different intraluminal device which may be used in the present invention.
- FIG. 3 is a perspective view of the intraluminal device of FIG. 1 illustrating the device having a polytetrafluoroethylene cover on both the inner and outer surface of the device.
- FIG. 4 is a cross-sectional view of the same intraluminal device shown in FIG. 3.
- FIG. 5 is the same intraluminal device as in FIG. 3 illustrating only the outer surface cover.
- FIG. 6 is the same intraluminal device as in FIG. 3 with the exception that only a liner or inner surface cover is shown.
- FIG. 7 is a cross-section of the porous PTFE material of the present invention.
- FIG. 8 is a schematic representation of ePTFE prior art.
- the present invention provides a covered stent which may be implanted intraluminally within a body vessel and disposed adjacent an occluded, weakened or otherwise damaged portion of the vessel so as to hold the vessel open.
- the covered stent is typically delivered intraluminally via a balloon catheter.
- the device is delivered in a compressed condition and once properly positioned may be deployed by radial expansion.
- the most common form of deploying the intraluminal device is by balloon expansion, however, the present invention may also be deployed by use of a self-expanding stent.
- FIG. 1 illustrates an intraluminal device in the form of a stent 12 .
- FIG. 2 illustrates an intraluminal device in the form of a stent 5 having a different construction than that shown in FIG. 1.
- FIG. 3 illustrates generally at 10 an intraluminal device in the form of a stent 12 as shown in FIG. 1 having a cover 14 on the outer surface 12 and liner 16 on the inner surface, both of which may be of the porous structure shown below in FIG. 7.
- the stent may optionally have only a cover 14 as shown in FIG. 5, or only a liner 16 as shown in FIG. 6, or both as shown in FIG. 3.
- the stent has both a cover 14 and a liner 16 .
- the liner, cover, or both, will be referred to hereinafter collectively as a cover or covering.
- the cover provides an effective barrier about the stent 12 preventing excessive cell or tissue ingrowth or thrombus formation through the expanded wall of the stent 12 .
- FIG. 4 is a cross-sectional view of the same device as shown in FIG. 3 with a cover 14 and a liner 16 around stent 12 .
- FIG. 1 is a more detailed illustration of stent 10 and shows generally an elongate tube.
- the body of stent 12 defines an opposed interior surface 11 and an exterior surface 13 and is formed of a generally open configuration having a plurality of openings or passages provided for longitudinal flexibility of the stent as well as permitting the stent to be radially expanded once deployed in the body lumen.
- Both the interior surface 11 and the exterior surface 13 may have the porous PTFE covering of the present invention.
- the covering On the interior surface the covering is referred to as the liner 12 as shown in FIG. 1 and on the exterior surface it is referred to as a cover 14 as shown in FIG. 1.
- Stent 12 may be employed in combination with a cover 14 or liner 16 but is preferably employed with both.
- the cover 14 may be applied over the tubular stent 12 so as to fully circumferentially surround the stent 12
- the liner 16 is applied inside and through the stent 12 so that the stent 12 fully circumferentially surrounds the liner 16 .
- the porous polytetrafluoroethylene (PTFE) material useful herein is first obtained in the form of an interpenetrating network of PTFE and siloxane, in particular, polydimethylsiloxane.
- the silicone is then extracted from the IPN using either thermal or chemical means. The removal of the silicone leaves behind a porous PTFE structure.
- a particular material for use herein is Silon®, an interpenetrating polymer network (IPN) of polytetrafluoroethylene (PTFE) and polydimethylsiloxane (silicone) supplied by Bio Med Sciences, Inc. located in Bethlehem, PA.
- IPN interpenetrating polymer network
- PTFE polytetrafluoroethylene
- silicone polydimethylsiloxane
- FIG. 7 illustrates generally at 20 a porous PTFE structure after removal of the siloxane.
- the removal of the siloxane leaves behind the porous structure wherein voids or pockets of air 25 , are found intermeshed in between pockets of PTFE 30 .
- the novel porous PTFE structure produced by the present inventive process is quite different from the porous structure produced by PTFE which has been stretched, or expanded.
- PTFE which has been stretched, or ePTFE has a node and fibril structure as seen in FIG. 8. After stretching, the ePTFE possesses nodes 32 connected to fibrils 34 . In between the nodes and fibrils are pores 36 .
- Removing the siloxane from the IPN of siloxane/PTFE through the use of heat involves heating the IPN structure to temperatures of between about 300° C. and about 390° C.
- Chemical removal of the siloxane may be accomplished using a compound selected from the group consisting of toluene, heptane, chloroform.
- Sintering is typically accomplished at or above the crystalline melting point of PTFE. Sintering is synonymous with recrystallization. It refers to the bonding of particles in a mass by molecular (or atomic) attraction in the solid state through the application of heat below the melting point of the polymer. Sintering causes the strengthening of the powder mass and normally results in densification and often recrystallization.
- a PTFE tube may be extruded as a tube from an extrusion device, or extruded as a film and subsequently wrapped into a tube. Extrusion techniques of PTFE are well known in the art.
- the stent may be covered on the interior surface 11 of the stent 10 , the exterior surface 13 of the stent 10 , or both.
- the stent 10 is covered on both the interior 11 and the exterior 13 surfaces of the stent 10 . Having the entire surface of the stent 10 covered with the porous PTFE of the present invention provides an effective barrier about the stent 10 preventing excessive cell or tissue growth, or thrombus formation through the expanded wall of a tubular stent 10 .
- the material In order for the covering of porous PTFE to function effectively in combination with an expandable stent, the material must exhibit sufficient expansion characteristics so as to enable the stent cover to expand along with the radial expansion of the stent 10 . If the covering material does not effectively expand with the stent, several problems can arise. The covering material may tear, and may even detach from the surface of the stent if improper or dissimilar expansion of the covering material occurs with the expansion of the stent.
- the PTFE may be fused or welded around or to the metal stent. This may be accomplished either through a heating process and/or bonding process. If heating is utilized, typically the PTFE will be heated above its sintering temperature.
- an adhesive preferably a biocompatible adhesive is used.
- adhesives are known to one of skill in the art and include, for example, polyurethanes, epoxies, cyanoacrylates, polyamides, polyimides, silicones, and so forth. Dispersions of PTFE or FEP (fluoroethylpropylene) may also be utilized. This list is not exclusive and is intended for illustrative purposes only, and is in no way intended as a limitation on the scope of the present invention. There is a vast number of adhesives that can be used for such applications, limited by their biocompatibility, and by their ability to bond to polymeric materials (e.g. PTFE) and metals, particularly in aqueous environments.
- polymeric materials e.g. PTFE
- metals particularly in aqueous environments.
- the covering material may also be assembled to the intraluminal device in more than one piece. Such a combination would require overlapping of sorts of the PTFE material, and subsequent fusion or adhesive bonding of the porous PTFE material to itself.
- porous PTFE covering in a continuous form such as a membrane or thin film.
- the porous PTFE (after removal of the siloxane), in the form of a membrane or a thin film, thus, preferably completely wraps the metal stent, thereby providing a barrier that physically isolates the stent from surrounding blood and tissue. This barrier further helps prevent healing or diseased layers of tissue from directly contacting the stent, or from passing through the stent in any way.
- the porous PTFE allows the passage of fluids and vital materials, however, while still serving as a barrier to tissue growth.
Abstract
An endoprosthesis device and method of making it are disclosed. More particularly, the endoprosthesis is a porous PTFE article used in conjunction with a stent.
Description
- The present invention relates to an endoprosthesis device or intraluminal device, in particular a stent, having a covering comprising porous polytetrafluoroethylene formed by removing the siloxane from an interpenetrating network of polytetrafluoroethylene and siloxane, and to a method of making the endoprosthesis device. The stent covering can be applied on the exterior surface of the stent, on the interior surface of the stent, or both, at a thickness of as low as about 15 microns.
- Endoprosthesis devices including stents, stent-grafts, grafts, vena cava filters, balloon catheters, and so forth, are placed or implanted within various body vessels for the treatment of various diseases. One particular type of an endoprosthesis device is the stent. A stent is implanted within a vessel for the treatment of stenoses, strictures, or aneurysms in the blood vessels. The devices are implanted within the vascular system to reinforce diseased, partially occluded, weakened or abnormally dilated sections of the blood vessel. Stents are often employed after angioplasty to prevent restenosis of a diseased blood vessel. While stents are most notably used in blood vessels, they have also been implanted in other bodily vessels including urinary tracts and bile ducts to reinforce and prevent neoplastic growth.
- Stents are typically longitudinal tubular devices formed of biocompatible materials and come in a variety of construction types, and are often expandable in nature. Many if not all of the materials used for stents involve metal or carbon fiber materials which are highly electro-positive and are bio-active. Since stents tend to be used under conditions were they are counteracting disease processes, supporting healing processes, or guarding against stenosis of a passage, bio-activity, which may encourage undesirable or poorly regulated growth processes, or lead to clot formation, should be avoided.
- Coating of the stent can keep the stent from directly contacting surrounding tissue or fluids, and thus can theoretically protect against unwanted electrochemically induced tissue reactions.
- In the field of expandable stents, a further problem arises due to the fact that many stent constructions involve structures that have numerous apertures or spaces between various strands or structural elements of the stent such as those structures that are filamentous, wire-like, or of a tubular nature in which various openings have been cut or etched into the stent. With these constructions, tissue may grow through the openings of the stent. Furthermore, the stent itself may provoke a foreign body reaction and be both a stimulus for and a framework supporting, proliferative tissue growth, resulting, for example, in scar tissue or restenosis of the very region it is placed to control.
- One approach to this drawback is to provide a coating, liner, cover or both, for the stent which prevents the healing or diseased layer of tissue from directly contacting the stent, or from passing through the stent in any way. Such liners may be formed, for example, of porous polytetrafluoroethylene (PTFE) which allows the passage of fluids and vital materials while serving as a barrier to tissue growth. However, when applying such a construction, a further difficulty which may arise is that the layer or sleeve of polymer must be attached to the stent for example, by staples or sutures at one end, or is prone to developing loose pockets or folds which might accumulate organic matter or lead to sepsis or unusual growth. Also, the necessarily thin liner material may detach or degrade. The risk of loose or unattached liner material is particularly great for constructions which utilize poorly adherent polymers, such as PTFE, or structures which seek to combine an expandable stent of stiff material, which changes both its dimension and its shape, with a dissimilar liner or shell.
- One method for overcoming these problems is found in U.S. Pat. No. 6,010,529 in which tube of polymeric material, e.g. expanded polytetrafluoroethylene (PTFE), is passed through the interior of a stent body and is turned back upon itself over the stent to form a cuff. The assembly is then heated and the outer layer contacts and coalesces with the inner layer, closely surrounding the stent body within a folded envelope having a continuous and seamless end. Porosity is imparted to the PTFE by previous stretching or expansion the material.
- Another type of covered stent which permits radial expansion is shown in WO 96/00103. As shown and described therein, a metallic expandable stent includes an outer covering of ePTFE. The ePTFE cover exhibits suitable expansion capabilities so as to enable the cover to expand upon expansion of the underlying stent. A polytetrafluoroethylene/lubricant blend may be extruded into a tube and the tube heated to remove the lubricant. Then, in order to impart the expandable characteristics to the ePTFE cover during formation of the ePTFE cover material, the ePTFE must undergo successive processing steps of expanding the material, sintering the material, radially dilating the material and resintering the dilated material, a procedure that is quite process intensive. The device described therefore requires precise manufacturing techniques and is extremely processing sensitive. Careful processing of the material forming the cover is required in order for the cover to exhibit sufficient expansion capabilities.
- U.S. Pat. No. 5,824,046 describes a composite intraluminal device, in particular an elongate radially expandable tubular stent having an interior luminal surface and an opposed exterior surface extending along a longitudinal stent axis. A stent cover is formed of unsintered ePTFE which is expandable.
- There remains a need in the art to provide a stent with a cover material that is sufficiently expandable, has the requisite barrier properties and yet allows the passage of fluids and vital materials, without requiring extensive processing procedures and is thus easily manufactured and applied to the stent.
- The present invention relates to a method of forming porous polytetrafluoroethylene (PTFE) without having to stretch or expand the material, and to a radially expandable endoprosthesis device covered with the solid but expandable polymer covering comprising the porous PTFE material obtained using the method of the present invention. The porous PTFE covering physically isolates the endoprosthesis from surrounding blood and tissue.
- Specifically, the porous PTFE is prepared by extracting siloxane from an interpenetrating network (IPN) of PTFE and siloxane, leaving behind a porous PTFE structure without having to expand and stretch the PTFE. Consequently, the PTFE material used in the endoprosthesis device coverings of the present invention is not expanded PTFE, but it is porous.
- In one embodiment the end of the prosthesis device of the present invention includes an elongate radially expandable tubular stent having an interior surface and in exterior surface extending along a longitudinal stent access. The expandable tubular stent has a stent cover on said interior surface, exterior surface or both, the cover being formed of a porous polytetrafluoroethylene. The porous polytetraflouroethylene cover is a non-stretched porous structure, the non-stretched structure lacking note and viable structure.
- In particular, the present invention relates to a radially expandable stent for use in treating stenoses wherein the stent is covered with an expandable polymer covering comprising the porous PTFE prepared according to the present invention that physically isolates the stent from surrounding blood and tissue.
- FIG. 1 is a perspective view of one type of intraluminal device that may be used in the present invention.
- FIG. 2 is a perspective view of a different intraluminal device which may be used in the present invention.
- FIG. 3 is a perspective view of the intraluminal device of FIG. 1 illustrating the device having a polytetrafluoroethylene cover on both the inner and outer surface of the device.
- FIG. 4 is a cross-sectional view of the same intraluminal device shown in FIG. 3.
- FIG. 5 is the same intraluminal device as in FIG. 3 illustrating only the outer surface cover.
- FIG. 6 is the same intraluminal device as in FIG. 3 with the exception that only a liner or inner surface cover is shown.
- FIG. 7 is a cross-section of the porous PTFE material of the present invention.
- FIG. 8 is a schematic representation of ePTFE prior art.
- The present invention provides a covered stent which may be implanted intraluminally within a body vessel and disposed adjacent an occluded, weakened or otherwise damaged portion of the vessel so as to hold the vessel open. The covered stent is typically delivered intraluminally via a balloon catheter. The device is delivered in a compressed condition and once properly positioned may be deployed by radial expansion. The most common form of deploying the intraluminal device is by balloon expansion, however, the present invention may also be deployed by use of a self-expanding stent.
- FIG. 1 illustrates an intraluminal device in the form of a
stent 12. FIG. 2 illustrates an intraluminal device in the form of astent 5 having a different construction than that shown in FIG. 1. - FIG. 3 illustrates generally at10 an intraluminal device in the form of a
stent 12 as shown in FIG. 1 having acover 14 on theouter surface 12 andliner 16 on the inner surface, both of which may be of the porous structure shown below in FIG. 7. The stent may optionally have only acover 14 as shown in FIG. 5, or only aliner 16 as shown in FIG. 6, or both as shown in FIG. 3. In a preferred embodiment, the stent has both acover 14 and aliner 16. The liner, cover, or both, will be referred to hereinafter collectively as a cover or covering. The cover provides an effective barrier about thestent 12 preventing excessive cell or tissue ingrowth or thrombus formation through the expanded wall of thestent 12. - FIG. 4 is a cross-sectional view of the same device as shown in FIG. 3 with a
cover 14 and aliner 16 aroundstent 12. - FIG. 1 is a more detailed illustration of
stent 10 and shows generally an elongate tube. The body ofstent 12 defines an opposed interior surface 11 and an exterior surface 13 and is formed of a generally open configuration having a plurality of openings or passages provided for longitudinal flexibility of the stent as well as permitting the stent to be radially expanded once deployed in the body lumen. Both the interior surface 11 and the exterior surface 13 may have the porous PTFE covering of the present invention. On the interior surface the covering is referred to as theliner 12 as shown in FIG. 1 and on the exterior surface it is referred to as acover 14 as shown in FIG. 1. - While the figures illustrate a particular construction of
stent 10, one of skill in the art would recognize that the porous PTFE covering material as described by the present invention would find utility in any stent configuration, and in particular the open stent configurations. -
Stent 12 may be employed in combination with acover 14 orliner 16 but is preferably employed with both. Thecover 14 may be applied over thetubular stent 12 so as to fully circumferentially surround thestent 12, while theliner 16 is applied inside and through thestent 12 so that thestent 12 fully circumferentially surrounds theliner 16. - The porous polytetrafluoroethylene (PTFE) material useful herein is first obtained in the form of an interpenetrating network of PTFE and siloxane, in particular, polydimethylsiloxane. The silicone is then extracted from the IPN using either thermal or chemical means. The removal of the silicone leaves behind a porous PTFE structure. A particular material for use herein is Silon®, an interpenetrating polymer network (IPN) of polytetrafluoroethylene (PTFE) and polydimethylsiloxane (silicone) supplied by Bio Med Sciences, Inc. located in Bethlehem, PA. Such IPN polymer networks are described in U.S. Pat. No. 6,022,902 incorporated by reference herein in its entirety. In this patent, Silon® is described as a breathable, hydrophobic polysiloxane membrane reinforced with poly(tetrafluoroethylene).
- The removal of the siloxane from the IPN leaves behind a porous PTFE structure without having to go through the added steps of stretching or expanding the PTFE in order to obtain the porous structure. Quite obviously, this simplifies the manufacturing process by decreasing the number of steps required, and also increases efficiency. Typically, porous PTFE requires the expanding and stretching steps in order to achieve the porous structure. FIG. 7 illustrates generally at20 a porous PTFE structure after removal of the siloxane. The removal of the siloxane leaves behind the porous structure wherein voids or pockets of
air 25, are found intermeshed in between pockets ofPTFE 30. - The novel porous PTFE structure produced by the present inventive process is quite different from the porous structure produced by PTFE which has been stretched, or expanded. Typically, PTFE which has been stretched, or ePTFE has a node and fibril structure as seen in FIG. 8. After stretching, the ePTFE possesses
nodes 32 connected to fibrils 34. In between the nodes and fibrils are pores 36. - Removing the siloxane from the IPN of siloxane/PTFE through the use of heat involves heating the IPN structure to temperatures of between about 300° C. and about 390° C. Chemical removal of the siloxane may be accomplished using a compound selected from the group consisting of toluene, heptane, chloroform.
- Sintering is typically accomplished at or above the crystalline melting point of PTFE. Sintering is synonymous with recrystallization. It refers to the bonding of particles in a mass by molecular (or atomic) attraction in the solid state through the application of heat below the melting point of the polymer. Sintering causes the strengthening of the powder mass and normally results in densification and often recrystallization.
- A PTFE tube may be extruded as a tube from an extrusion device, or extruded as a film and subsequently wrapped into a tube. Extrusion techniques of PTFE are well known in the art.
- As discussed above, the stent may be covered on the interior surface11 of the
stent 10, the exterior surface 13 of thestent 10, or both. Preferably, thestent 10 is covered on both the interior 11 and the exterior 13 surfaces of thestent 10. Having the entire surface of thestent 10 covered with the porous PTFE of the present invention provides an effective barrier about thestent 10 preventing excessive cell or tissue growth, or thrombus formation through the expanded wall of atubular stent 10. - In order for the covering of porous PTFE to function effectively in combination with an expandable stent, the material must exhibit sufficient expansion characteristics so as to enable the stent cover to expand along with the radial expansion of the
stent 10. If the covering material does not effectively expand with the stent, several problems can arise. The covering material may tear, and may even detach from the surface of the stent if improper or dissimilar expansion of the covering material occurs with the expansion of the stent. - In order to improve the adhesion, and further prevent detachment of the PTFE covering from the stent, the PTFE may be fused or welded around or to the metal stent. This may be accomplished either through a heating process and/or bonding process. If heating is utilized, typically the PTFE will be heated above its sintering temperature.
- If an adhesive is utilized, preferably a biocompatible adhesive is used. Such adhesives are known to one of skill in the art and include, for example, polyurethanes, epoxies, cyanoacrylates, polyamides, polyimides, silicones, and so forth. Dispersions of PTFE or FEP (fluoroethylpropylene) may also be utilized. This list is not exclusive and is intended for illustrative purposes only, and is in no way intended as a limitation on the scope of the present invention. There is a vast number of adhesives that can be used for such applications, limited by their biocompatibility, and by their ability to bond to polymeric materials (e.g. PTFE) and metals, particularly in aqueous environments.
- The covering material may also be assembled to the intraluminal device in more than one piece. Such a combination would require overlapping of sorts of the PTFE material, and subsequent fusion or adhesive bonding of the porous PTFE material to itself.
- It is preferable, however, to utilize the porous PTFE covering in a continuous form such as a membrane or thin film. The porous PTFE (after removal of the siloxane), in the form of a membrane or a thin film, thus, preferably completely wraps the metal stent, thereby providing a barrier that physically isolates the stent from surrounding blood and tissue. This barrier further helps prevent healing or diseased layers of tissue from directly contacting the stent, or from passing through the stent in any way. The porous PTFE allows the passage of fluids and vital materials, however, while still serving as a barrier to tissue growth.
Claims (13)
1. An endoprosthesis device comprising:
an elongate radially expandable tubular stent having an interior surface and an exterior surface extending along a longitudinal stent axis; and
a stent cover on said interior surface, exterior surface or both, said stent cover being formed of a polytetrafluoroethylene having no node and fibril structure;
wherein said porous polytetrafluoroethylene is formed by the steps of:
providing an interpenetrating network of siloxane/polytetrafluoroethylene;
removing said siloxane from said interpenetrating network leaving a porous polytetrafluoroethylene structure without a node and fibril structure.
2. The endoprosthesis device of claim 1 wherein said stent cover is on said exterior surface and said interior surface of said stent.
3. The endoprosthesis device of claim 1 wherein said stent cover is expandable upon expansion of said stent.
4. The endoprosthesis device of claim 1 wherein said siloxane is chemically extracted from said siloxane/polytetrafluoroethylene interpenetrating network.
5. The endoprosthesis device of claim 4 wherein said siloxane is chemically extracted by a compound selected from the group consisting of toluene, heptane and chloroform.
6. The endoprosthesis device of claim 1 wherein said siloxane is removed from said siloxane/polytetrafluoroethylene interpenetrating network by heating said network to a temperature of at least about 300° C.
7-12 (canceled).
13. An endoprosthesis device comprising:
an elongate radially expandable tubular stent having an interior surface and an exterior surface extending along a longitudinal stent axis; and
a stent cover on said interior surface, exterior surface or both, which is formed of a polytetrafluoroethylene having no node and fibril structure;
wherein said porous polytetrafluoroethylene comprises a porous structure—having voids intermeshed between pockets of PTFE without a node and fibril structure.
14 (canceled).
15. The endoprosthesis device of claim 13 wherein said stent cover is on said exterior surface and said interior surface of said stent.
16. The endoprosthesis device of claim 13 wherein said stent cover is expandable upon expansion of said stent.
17. The endoprosthesis device of claim 1 wherein said siloxane is polydimethylsiloxane.
18. The method of claim 7 wherein said siloxane is polydimethylsiloxane.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/858,589 US20040220659A1 (en) | 2000-11-02 | 2004-06-02 | Stent covering formed of porous polytetraflouroethylene |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/704,494 US6770086B1 (en) | 2000-11-02 | 2000-11-02 | Stent covering formed of porous polytetraflouroethylene |
US10/858,589 US20040220659A1 (en) | 2000-11-02 | 2004-06-02 | Stent covering formed of porous polytetraflouroethylene |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/704,494 Continuation US6770086B1 (en) | 2000-11-02 | 2000-11-02 | Stent covering formed of porous polytetraflouroethylene |
Publications (1)
Publication Number | Publication Date |
---|---|
US20040220659A1 true US20040220659A1 (en) | 2004-11-04 |
Family
ID=24829763
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/704,494 Expired - Lifetime US6770086B1 (en) | 2000-11-02 | 2000-11-02 | Stent covering formed of porous polytetraflouroethylene |
US10/002,521 Abandoned US20020111667A1 (en) | 2000-11-02 | 2001-11-01 | Non-expanded porous polytetrafluoroethylene (PTFE) products and methods of manufacture |
US10/858,589 Abandoned US20040220659A1 (en) | 2000-11-02 | 2004-06-02 | Stent covering formed of porous polytetraflouroethylene |
Family Applications Before (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/704,494 Expired - Lifetime US6770086B1 (en) | 2000-11-02 | 2000-11-02 | Stent covering formed of porous polytetraflouroethylene |
US10/002,521 Abandoned US20020111667A1 (en) | 2000-11-02 | 2001-11-01 | Non-expanded porous polytetrafluoroethylene (PTFE) products and methods of manufacture |
Country Status (7)
Country | Link |
---|---|
US (3) | US6770086B1 (en) |
EP (2) | EP2275248A1 (en) |
JP (1) | JP3853734B2 (en) |
AT (1) | ATE485936T1 (en) |
AU (1) | AU2002225830A1 (en) |
DE (1) | DE60143364D1 (en) |
WO (1) | WO2002036332A2 (en) |
Cited By (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20020111667A1 (en) * | 2000-11-02 | 2002-08-15 | Scimed Life Systems, Inc. | Non-expanded porous polytetrafluoroethylene (PTFE) products and methods of manufacture |
US7955382B2 (en) | 2006-09-15 | 2011-06-07 | Boston Scientific Scimed, Inc. | Endoprosthesis with adjustable surface features |
US7985252B2 (en) | 2008-07-30 | 2011-07-26 | Boston Scientific Scimed, Inc. | Bioerodible endoprosthesis |
US7998192B2 (en) | 2008-05-09 | 2011-08-16 | Boston Scientific Scimed, Inc. | Endoprostheses |
US8002821B2 (en) | 2006-09-18 | 2011-08-23 | Boston Scientific Scimed, Inc. | Bioerodible metallic ENDOPROSTHESES |
US8048150B2 (en) | 2006-04-12 | 2011-11-01 | Boston Scientific Scimed, Inc. | Endoprosthesis having a fiber meshwork disposed thereon |
US8052745B2 (en) | 2007-09-13 | 2011-11-08 | Boston Scientific Scimed, Inc. | Endoprosthesis |
US8052743B2 (en) | 2006-08-02 | 2011-11-08 | Boston Scientific Scimed, Inc. | Endoprosthesis with three-dimensional disintegration control |
US8052744B2 (en) | 2006-09-15 | 2011-11-08 | Boston Scientific Scimed, Inc. | Medical devices and methods of making the same |
US8057534B2 (en) | 2006-09-15 | 2011-11-15 | Boston Scientific Scimed, Inc. | Bioerodible endoprostheses and methods of making the same |
US8080055B2 (en) | 2006-12-28 | 2011-12-20 | Boston Scientific Scimed, Inc. | Bioerodible endoprostheses and methods of making the same |
US8089029B2 (en) | 2006-02-01 | 2012-01-03 | Boston Scientific Scimed, Inc. | Bioabsorbable metal medical device and method of manufacture |
US8128689B2 (en) | 2006-09-15 | 2012-03-06 | Boston Scientific Scimed, Inc. | Bioerodible endoprosthesis with biostable inorganic layers |
US8236046B2 (en) | 2008-06-10 | 2012-08-07 | Boston Scientific Scimed, Inc. | Bioerodible endoprosthesis |
US8267992B2 (en) | 2009-03-02 | 2012-09-18 | Boston Scientific Scimed, Inc. | Self-buffering medical implants |
US8303643B2 (en) | 2001-06-27 | 2012-11-06 | Remon Medical Technologies Ltd. | Method and device for electrochemical formation of therapeutic species in vivo |
US8382824B2 (en) | 2008-10-03 | 2013-02-26 | Boston Scientific Scimed, Inc. | Medical implant having NANO-crystal grains with barrier layers of metal nitrides or fluorides |
US8668732B2 (en) | 2010-03-23 | 2014-03-11 | Boston Scientific Scimed, Inc. | Surface treated bioerodible metal endoprostheses |
US8808726B2 (en) | 2006-09-15 | 2014-08-19 | Boston Scientific Scimed. Inc. | Bioerodible endoprostheses and methods of making the same |
US8840660B2 (en) | 2006-01-05 | 2014-09-23 | Boston Scientific Scimed, Inc. | Bioerodible endoprostheses and methods of making the same |
Families Citing this family (79)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6579314B1 (en) * | 1995-03-10 | 2003-06-17 | C.R. Bard, Inc. | Covered stent with encapsulated ends |
US6264684B1 (en) | 1995-03-10 | 2001-07-24 | Impra, Inc., A Subsidiary Of C.R. Bard, Inc. | Helically supported graft |
US6451047B2 (en) | 1995-03-10 | 2002-09-17 | Impra, Inc. | Encapsulated intraluminal stent-graft and methods of making same |
US6395019B2 (en) | 1998-02-09 | 2002-05-28 | Trivascular, Inc. | Endovascular graft |
US7500988B1 (en) * | 2000-11-16 | 2009-03-10 | Cordis Corporation | Stent for use in a stent graft |
US6398803B1 (en) | 1999-02-02 | 2002-06-04 | Impra, Inc., A Subsidiary Of C.R. Bard, Inc. | Partial encapsulation of stents |
US7090693B1 (en) | 2001-12-20 | 2006-08-15 | Boston Scientific Santa Rosa Corp. | Endovascular graft joint and method for manufacture |
US7125464B2 (en) | 2001-12-20 | 2006-10-24 | Boston Scientific Santa Rosa Corp. | Method for manufacturing an endovascular graft section |
US6776604B1 (en) * | 2001-12-20 | 2004-08-17 | Trivascular, Inc. | Method and apparatus for shape forming endovascular graft material |
US20040093056A1 (en) | 2002-10-26 | 2004-05-13 | Johnson Lianw M. | Medical appliance delivery apparatus and method of use |
US7959671B2 (en) | 2002-11-05 | 2011-06-14 | Merit Medical Systems, Inc. | Differential covering and coating methods |
US7637942B2 (en) | 2002-11-05 | 2009-12-29 | Merit Medical Systems, Inc. | Coated stent with geometry determinated functionality and method of making the same |
US7875068B2 (en) | 2002-11-05 | 2011-01-25 | Merit Medical Systems, Inc. | Removable biliary stent |
WO2004043300A1 (en) * | 2002-11-07 | 2004-05-27 | Abbott Laboratories | Prosthesis with multiple drugs in discrete unmixed droplets |
JP2006514848A (en) * | 2002-11-13 | 2006-05-18 | セタゴン インコーポレーティッド | Medical device having porous layer and method for producing the same |
US20060121080A1 (en) * | 2002-11-13 | 2006-06-08 | Lye Whye K | Medical devices having nanoporous layers and methods for making the same |
US7637934B2 (en) | 2003-03-31 | 2009-12-29 | Merit Medical Systems, Inc. | Medical appliance optical delivery and deployment apparatus and method |
US20050113904A1 (en) * | 2003-11-25 | 2005-05-26 | Shank Peter J. | Composite stent with inner and outer stent elements and method of using the same |
US8435285B2 (en) | 2003-11-25 | 2013-05-07 | Boston Scientific Scimed, Inc. | Composite stent with inner and outer stent elements and method of using the same |
US7195644B2 (en) * | 2004-03-02 | 2007-03-27 | Joint Synergy, Llc | Ball and dual socket joint |
CA2915597C (en) * | 2004-09-17 | 2018-01-23 | Cordis Neurovascular, Inc. | Thin film devices for occlusion of a vessel |
US20060079954A1 (en) * | 2004-10-08 | 2006-04-13 | Robert Burgermeister | Geometry and material for high strength, high flexibility, controlled recoil stent |
WO2006058233A1 (en) * | 2004-11-24 | 2006-06-01 | Donaldson Company, Inc. | Ptfe membrane |
US20080140172A1 (en) * | 2004-12-13 | 2008-06-12 | Robert Hunt Carpenter | Multi-Wall Expandable Device Capable Of Drug Delivery Related Applications |
US7806922B2 (en) * | 2004-12-31 | 2010-10-05 | Boston Scientific Scimed, Inc. | Sintered ring supported vascular graft |
US20060149366A1 (en) * | 2004-12-31 | 2006-07-06 | Jamie Henderson | Sintered structures for vascular graft |
US7524445B2 (en) * | 2004-12-31 | 2009-04-28 | Boston Scientific Scimed, Inc. | Method for making ePTFE and structure containing such ePTFE, such as a vascular graft |
US7857843B2 (en) * | 2004-12-31 | 2010-12-28 | Boston Scientific Scimed, Inc. | Differentially expanded vascular graft |
US8535702B2 (en) | 2005-02-01 | 2013-09-17 | Boston Scientific Scimed, Inc. | Medical devices having porous polymeric regions for controlled drug delivery and regulated biocompatibility |
US7789888B2 (en) * | 2005-02-14 | 2010-09-07 | Bartee Chad M | PTFE composite multi-layer material |
US20060233991A1 (en) | 2005-04-13 | 2006-10-19 | Trivascular, Inc. | PTFE layers and methods of manufacturing |
US20060233990A1 (en) | 2005-04-13 | 2006-10-19 | Trivascular, Inc. | PTFE layers and methods of manufacturing |
US8163002B2 (en) * | 2005-11-14 | 2012-04-24 | Vascular Devices Llc | Self-sealing vascular graft |
US7867176B2 (en) * | 2005-12-27 | 2011-01-11 | Cordis Corporation | Variable stiffness guidewire |
US20070203564A1 (en) * | 2006-02-28 | 2007-08-30 | Boston Scientific Scimed, Inc. | Biodegradable implants having accelerated biodegradation properties in vivo |
US8025693B2 (en) * | 2006-03-01 | 2011-09-27 | Boston Scientific Scimed, Inc. | Stent-graft having flexible geometries and methods of producing the same |
US7785317B2 (en) | 2006-03-29 | 2010-08-31 | Codman & Shurtleff, Inc. | Joined metal tubing and method of manufacture |
US7666496B2 (en) | 2006-05-24 | 2010-02-23 | Boston Scientific Scimed, Inc. | Micro-sintered node ePTFE structure |
US7766935B2 (en) | 2006-06-12 | 2010-08-03 | Codman & Shurtleff, Inc. | Modified headpiece for hydraulic coil deployment system |
US7670353B2 (en) * | 2006-06-12 | 2010-03-02 | Codman & Shurtleff, Inc. | Modified headpiece for hydraulic coil deployment system |
US8585732B2 (en) * | 2006-06-14 | 2013-11-19 | DePuy Synthes Products, LLC | Retrieval device with sidewall grippers |
EP2073765A2 (en) * | 2006-09-25 | 2009-07-01 | Boston Scientific Limited | Injection of therapeutic into porous regions of a medical device |
JP5037087B2 (en) * | 2006-10-31 | 2012-09-26 | 日本バルカー工業株式会社 | Method for forming porous PTFE layer, and porous PTFE layer and molded article obtained by this forming method |
US8226701B2 (en) | 2007-09-26 | 2012-07-24 | Trivascular, Inc. | Stent and delivery system for deployment thereof |
US8663309B2 (en) | 2007-09-26 | 2014-03-04 | Trivascular, Inc. | Asymmetric stent apparatus and method |
US8066755B2 (en) | 2007-09-26 | 2011-11-29 | Trivascular, Inc. | System and method of pivoted stent deployment |
JP2010540190A (en) | 2007-10-04 | 2010-12-24 | トリバスキュラー・インコーポレイテッド | Modular vascular graft for low profile transdermal delivery |
US8142490B2 (en) * | 2007-10-24 | 2012-03-27 | Cordis Corporation | Stent segments axially connected by thin film |
US8083789B2 (en) | 2007-11-16 | 2011-12-27 | Trivascular, Inc. | Securement assembly and method for expandable endovascular device |
US8328861B2 (en) | 2007-11-16 | 2012-12-11 | Trivascular, Inc. | Delivery system and method for bifurcated graft |
US8196279B2 (en) | 2008-02-27 | 2012-06-12 | C. R. Bard, Inc. | Stent-graft covering process |
US8252048B2 (en) * | 2008-03-19 | 2012-08-28 | Boston Scientific Scimed, Inc. | Drug eluting stent and method of making the same |
US20130268062A1 (en) | 2012-04-05 | 2013-10-10 | Zeus Industrial Products, Inc. | Composite prosthetic devices |
EP3434225B1 (en) | 2009-06-23 | 2023-11-01 | Endospan Ltd. | Vascular prosthesis for treating aneurysms |
CA2767596C (en) | 2009-07-09 | 2015-11-24 | Endospan Ltd. | Apparatus for closure of a lumen and methods of using the same |
JP5456892B2 (en) | 2009-08-07 | 2014-04-02 | ゼウス インダストリアル プロダクツ インコーポレイテッド | Multilayer composite |
WO2011095979A1 (en) | 2010-02-08 | 2011-08-11 | Endospan Ltd. | Thermal energy application for prevention and management of endoleaks in stent-grafts |
US20110208289A1 (en) * | 2010-02-25 | 2011-08-25 | Endospan Ltd. | Flexible Stent-Grafts |
JP5661334B2 (en) * | 2010-05-26 | 2015-01-28 | テルモ株式会社 | Stent |
US8389041B2 (en) | 2010-06-17 | 2013-03-05 | Abbott Cardiovascular Systems, Inc. | Systems and methods for rotating and coating an implantable device |
US20130156720A1 (en) | 2010-08-27 | 2013-06-20 | Ironwood Pharmaceuticals, Inc. | Compositions and methods for treating or preventing metabolic syndrome and related diseases and disorders |
US8808848B2 (en) | 2010-09-10 | 2014-08-19 | W. L. Gore & Associates, Inc. | Porous article |
CA2826022A1 (en) * | 2011-02-03 | 2012-08-09 | Endospan Ltd. | Implantable medical devices constructed of shape memory material |
US9254209B2 (en) | 2011-07-07 | 2016-02-09 | Endospan Ltd. | Stent fixation with reduced plastic deformation |
US9839510B2 (en) | 2011-08-28 | 2017-12-12 | Endospan Ltd. | Stent-grafts with post-deployment variable radial displacement |
WO2013065040A1 (en) | 2011-10-30 | 2013-05-10 | Endospan Ltd. | Triple-collar stent-graft |
EP2785277B1 (en) | 2011-12-04 | 2017-04-05 | Endospan Ltd. | Branched stent-graft system |
US8992595B2 (en) | 2012-04-04 | 2015-03-31 | Trivascular, Inc. | Durable stent graft with tapered struts and stable delivery methods and devices |
US9498363B2 (en) | 2012-04-06 | 2016-11-22 | Trivascular, Inc. | Delivery catheter for endovascular device |
WO2013171730A1 (en) | 2012-05-15 | 2013-11-21 | Endospan Ltd. | Stent-graft with fixation elements that are radially confined for delivery |
EP2956180B1 (en) | 2013-02-15 | 2018-08-01 | Boston Scientific Scimed, Inc. | Bioerodible magnesium alloy microstructures for endoprostheses |
CA2929046A1 (en) | 2013-10-29 | 2015-05-07 | Boston Scientific Scimed, Inc. | Bioerodible magnesium alloy microstructures for endoprostheses |
WO2015075708A1 (en) | 2013-11-19 | 2015-05-28 | Endospan Ltd. | Stent system with radial-expansion locking |
JP6462117B2 (en) * | 2014-09-23 | 2019-01-30 | ボストン サイエンティフィック サイムド,インコーポレイテッドBoston Scientific Scimed,Inc. | Implantable medical device with shape memory polymer filter layer |
CN106029005B (en) | 2014-12-18 | 2018-01-19 | 恩都思潘有限公司 | The Endovascular stent-graft of horizontal conduit with tired resistance |
CN107427603A (en) | 2015-03-11 | 2017-12-01 | 波士顿科学国际有限公司 | Bioerodible magnesium alloy micro-structural for interior prosthese |
CN105802192A (en) * | 2016-04-29 | 2016-07-27 | 苏州林华医疗器械股份有限公司 | Novel material applied to indwelling needle catheter and preparation method thereof |
US20210221961A1 (en) * | 2020-01-16 | 2021-07-22 | Wisconsin Alumni Research Foundation | Methods of making polytetrafluoroethylene/polymer composites and uses thereof |
US20220211477A1 (en) * | 2021-01-06 | 2022-07-07 | Medtronic Inc. | Surgical system and methods of use |
Citations (74)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US1978A (en) * | 1841-02-13 | Manner of constructing- stoves | ||
US3407249A (en) * | 1966-01-25 | 1968-10-22 | American Cyanamid Co | Porous, extensively fibrillated polytetrafluoroethylene and method of preparing same |
US4196070A (en) * | 1977-12-12 | 1980-04-01 | Nuclepore Corporation | Method for forming microporous fluorocarbon polymer sheet and product |
US4289600A (en) * | 1978-03-31 | 1981-09-15 | Hooker Chemicals & Plastics Corp. | Microporous membrane materials |
US4304010A (en) * | 1978-10-12 | 1981-12-08 | Sumitomo Electric Industries, Ltd. | Tubular polytetrafluoroethylene prosthesis with porous elastomer coating |
US4321711A (en) * | 1978-10-18 | 1982-03-30 | Sumitomo Electric Industries, Ltd. | Vascular prosthesis |
US4533369A (en) * | 1982-05-28 | 1985-08-06 | Sumitomo Electric Industries, Ltd. | Gas-permselective composite membranes and process for the production thereof |
US4576608A (en) * | 1980-11-06 | 1986-03-18 | Homsy Charles A | Porous body-implantable polytetrafluoroethylene |
US4605406A (en) * | 1984-08-03 | 1986-08-12 | Medtronic, Inc. | Method for fabricating prosthesis material |
US4657544A (en) * | 1984-04-18 | 1987-04-14 | Cordis Corporation | Cardiovascular graft and method of forming same |
US4725273A (en) * | 1985-08-23 | 1988-02-16 | Kanegafuchi Kagaku Kogyo Kabushiki Kaisha | Artificial vessel having excellent patency |
US4764560A (en) * | 1985-11-13 | 1988-08-16 | General Electric Company | Interpenetrating polymeric network comprising polytetrafluoroethylene and polysiloxane |
US4822361A (en) * | 1985-12-24 | 1989-04-18 | Sumitomo Electric Industries, Ltd. | Tubular prosthesis having a composite structure |
US4828772A (en) * | 1984-10-09 | 1989-05-09 | Millipore Corporation | Microporous membranes of ultrahigh molecular weight polyethylene |
US4834746A (en) * | 1983-06-06 | 1989-05-30 | Kanegafuchi Kagaku Kogyo Kabushiki Kaisha | Artificial vessel and process for preparing the same |
US4849285A (en) * | 1987-06-01 | 1989-07-18 | Bio Med Sciences, Inc. | Composite macrostructure of ceramic and organic biomaterials |
US4863604A (en) * | 1987-02-05 | 1989-09-05 | Parker-Hannifin Corporation | Microporous asymmetric polyfluorocarbon membranes |
US4874568A (en) * | 1988-09-26 | 1989-10-17 | The Dow Chemical Company | Process of making a porous membrane |
US4906377A (en) * | 1988-05-04 | 1990-03-06 | Millipore Corporation | Fluorocarbon membranes and process for making fluorocarbon membranes |
US4945125A (en) * | 1987-01-05 | 1990-07-31 | Tetratec Corporation | Process of producing a fibrillated semi-interpenetrating polymer network of polytetrafluoroethylene and silicone elastomer and shaped products thereof |
US4951381A (en) * | 1988-10-03 | 1990-08-28 | Alps Electric Co., Ltd. | Method of manufacturing a magnetic head slider |
US4963304A (en) * | 1988-09-26 | 1990-10-16 | The Dow Chemical Company | Process for preparing microporous membranes |
US4986832A (en) * | 1987-09-04 | 1991-01-22 | Ube Industries, Ltd. | Artificial blood vessel and process for preparing it |
US4997603A (en) * | 1988-08-05 | 1991-03-05 | Hoechst Celanese Corp. | Process for formation of halogenated polymeric microporous membranes having improved strength properties |
US5066683A (en) * | 1987-01-05 | 1991-11-19 | Tetratec Corporation | Microporous waterproof and moisture vapor permeable structures, processes of manufacture and useful articles thereof |
US5098625A (en) * | 1989-03-14 | 1992-03-24 | Yeu Ming Tai Chemical Industrial Co., Ltd. | Process for forming an expanded porous tetrafluoroethylene polymer |
US5123917A (en) * | 1990-04-27 | 1992-06-23 | Lee Peter Y | Expandable intraluminal vascular graft |
US5141522A (en) * | 1990-02-06 | 1992-08-25 | American Cyanamid Company | Composite material having absorbable and non-absorbable components for use with mammalian tissue |
US5157058A (en) * | 1987-01-05 | 1992-10-20 | Tetratec Corporation | Microporous waterproof and moisture vapor permeable structures, processes of manufacture and useful articles thereof |
US5198162A (en) * | 1984-12-19 | 1993-03-30 | Scimat Limited | Microporous films |
US5248428A (en) * | 1991-06-28 | 1993-09-28 | Minnesota Mining And Manufacturing Company | Article for separations and purifications and method of controlling porosity therein |
US5433909A (en) * | 1992-03-13 | 1995-07-18 | Atrium Medical Corporation | Method of making controlled porosity expanded polytetrafluoroethylene products |
US5466509A (en) * | 1993-01-15 | 1995-11-14 | Impra, Inc. | Textured, porous, expanded PTFE |
US5474128A (en) * | 1993-07-02 | 1995-12-12 | Best Tool Co., Inc. | Telescoping conduits for increasing the fluid resistance of well production tubing inadvertently dropped in an oil or gas well |
US5607464A (en) * | 1991-02-28 | 1997-03-04 | Medtronic, Inc. | Prosthetic vascular graft with a pleated structure |
US5639278A (en) * | 1993-10-21 | 1997-06-17 | Corvita Corporation | Expandable supportive bifurcated endoluminal grafts |
US5641373A (en) * | 1995-04-17 | 1997-06-24 | Baxter International Inc. | Method of manufacturing a radially-enlargeable PTFE tape-reinforced vascular graft |
US5693085A (en) * | 1994-04-29 | 1997-12-02 | Scimed Life Systems, Inc. | Stent with collagen |
US5700285A (en) * | 1993-08-18 | 1997-12-23 | W. L. Gore & Associates, Inc. | Intraluminal stent graft |
US5716660A (en) * | 1994-08-12 | 1998-02-10 | Meadox Medicals, Inc. | Tubular polytetrafluoroethylene implantable prostheses |
US5723526A (en) * | 1993-09-08 | 1998-03-03 | Teijin Chemicals Ltd | Resin composition and molded article |
US5741326A (en) * | 1996-07-15 | 1998-04-21 | Cordis Corporation | Low profile thermally set wrapped cover for a percutaneously deployed stent |
US5744515A (en) * | 1995-05-26 | 1998-04-28 | Bsi Corporation | Method and implantable article for promoting endothelialization |
US5749880A (en) * | 1995-03-10 | 1998-05-12 | Impra, Inc. | Endoluminal encapsulated stent and methods of manufacture and endoluminal delivery |
US5769884A (en) * | 1996-06-27 | 1998-06-23 | Cordis Corporation | Controlled porosity endovascular implant |
US5776185A (en) * | 1994-09-27 | 1998-07-07 | Alessandro Verona | Cardiovascular graft |
US5782904A (en) * | 1993-09-30 | 1998-07-21 | Endogad Research Pty Limited | Intraluminal graft |
US5788626A (en) * | 1995-11-21 | 1998-08-04 | Schneider (Usa) Inc | Method of making a stent-graft covered with expanded polytetrafluoroethylene |
US5824046A (en) * | 1996-09-27 | 1998-10-20 | Scimed Life Systems, Inc. | Covered stent |
US5837752A (en) * | 1997-07-17 | 1998-11-17 | Massachusetts Institute Of Technology | Semi-interpenetrating polymer networks |
US5840775A (en) * | 1992-06-25 | 1998-11-24 | E. I. Du Pont De Nemours And Company | Porous polytetraflouroethylene and preparation |
US5843161A (en) * | 1996-06-26 | 1998-12-01 | Cordis Corporation | Endoprosthesis assembly for percutaneous deployment and method of deploying same |
US5925074A (en) * | 1996-12-03 | 1999-07-20 | Atrium Medical Corporation | Vascular endoprosthesis and method |
US5928280A (en) * | 1995-09-11 | 1999-07-27 | William Cook Europe A/S | Expandable endovascular stent |
US5928279A (en) * | 1996-07-03 | 1999-07-27 | Baxter International Inc. | Stented, radially expandable, tubular PTFE grafts |
US5980923A (en) * | 1994-02-23 | 1999-11-09 | Bio Med Sciences, Inc. | Semi-interpenetrating polymer network scar treatment sheeting, process of manufacture and useful articles thereof |
US6004348A (en) * | 1995-03-10 | 1999-12-21 | Impra, Inc. | Endoluminal encapsulated stent and methods of manufacture and endoluminal delivery |
US6010529A (en) * | 1996-12-03 | 2000-01-04 | Atrium Medical Corporation | Expandable shielded vessel support |
US6015609A (en) * | 1996-04-04 | 2000-01-18 | Navartis Ag | Process for manufacture of a porous polymer from a mixture |
US6022902A (en) * | 1989-10-31 | 2000-02-08 | The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration | Porous article with surface functionality and method for preparing same |
US6053943A (en) * | 1995-12-08 | 2000-04-25 | Impra, Inc. | Endoluminal graft with integral structural support and method for making same |
US6060530A (en) * | 1996-04-04 | 2000-05-09 | Novartis Ag | Process for manufacture of a porous polymer by use of a porogen |
US6143675A (en) * | 1995-06-07 | 2000-11-07 | W. L. Gore & Associates (Uk) Ltd. | Porous composite |
US6156064A (en) * | 1998-08-14 | 2000-12-05 | Schneider (Usa) Inc | Stent-graft-membrane and method of making the same |
US6190590B1 (en) * | 1996-02-28 | 2001-02-20 | Impra, Inc. | Apparatus and method for making flanged graft for end-to-side anastomosis |
US6235377B1 (en) * | 1995-09-05 | 2001-05-22 | Bio Med Sciences, Inc. | Microporous membrane with a stratified pore structure created in situ and process |
US6245099B1 (en) * | 1998-09-30 | 2001-06-12 | Impra, Inc. | Selective adherence of stent-graft coverings, mandrel and method of making stent-graft device |
US6293969B1 (en) * | 1997-01-29 | 2001-09-25 | Endovascular Technologies, Inc. | Bell-bottom modular stent-graft |
US6361559B1 (en) * | 1998-06-10 | 2002-03-26 | Converge Medical, Inc. | Thermal securing anastomosis systems |
US20020111667A1 (en) * | 2000-11-02 | 2002-08-15 | Scimed Life Systems, Inc. | Non-expanded porous polytetrafluoroethylene (PTFE) products and methods of manufacture |
US6540780B1 (en) * | 1998-11-23 | 2003-04-01 | Medtronic, Inc. | Porous synthetic vascular grafts with oriented ingrowth channels |
US6702965B2 (en) * | 1997-02-06 | 2004-03-09 | Bollore | Method of forming a porous composite product, in particular with a high specific surface |
US6770202B1 (en) * | 1999-04-14 | 2004-08-03 | Pall Corporation | Porous membrane |
US7083640B2 (en) * | 1995-03-10 | 2006-08-01 | C. R. Bard, Inc. | Covered stent with encapsulated ends |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA1283492C (en) | 1985-11-13 | 1991-04-23 | Tyrone D. Mitchell | Interpenetrating polymeric networks comprising polytetrafluoroethylene and polysiloxane |
JP3077859B2 (en) * | 1992-10-02 | 2000-08-21 | 田中貴金属工業株式会社 | Method for removing surfactant from material sheet for gas diffusion electrode |
ES2239322T3 (en) | 1994-06-27 | 2005-09-16 | Bard Peripheral Vascular, Inc. | RADIANTLY EXPANDABLE POLYETRAFLUORETILENE AND EXPANDABLE ENDOVASCULAR STENTS FORMED WITH THIS MATTER. |
US5747128A (en) | 1996-01-29 | 1998-05-05 | W. L. Gore & Associates, Inc. | Radially supported polytetrafluoroethylene vascular graft |
EP0971643A4 (en) * | 1996-12-03 | 2004-01-28 | Atrium Medical Corp | Multi-stage prosthesis |
ATE287679T1 (en) | 1997-03-05 | 2005-02-15 | Boston Scient Ltd | COMPLIANT MULTI-LAYER STENT DEVICE |
US6203536B1 (en) * | 1997-06-17 | 2001-03-20 | Medtronic, Inc. | Medical device for delivering a therapeutic substance and method therefor |
USH1978H1 (en) * | 1999-05-14 | 2001-08-07 | Kimberly-Clark Worldwide, Inc. | Monolithic films having zoned breathability |
-
2000
- 2000-11-02 US US09/704,494 patent/US6770086B1/en not_active Expired - Lifetime
-
2001
- 2001-11-01 DE DE60143364T patent/DE60143364D1/en not_active Expired - Lifetime
- 2001-11-01 WO PCT/US2001/045550 patent/WO2002036332A2/en active Application Filing
- 2001-11-01 JP JP2002539122A patent/JP3853734B2/en not_active Expired - Fee Related
- 2001-11-01 AU AU2002225830A patent/AU2002225830A1/en not_active Abandoned
- 2001-11-01 EP EP10011348A patent/EP2275248A1/en not_active Withdrawn
- 2001-11-01 EP EP01992638A patent/EP1385691B1/en not_active Expired - Lifetime
- 2001-11-01 US US10/002,521 patent/US20020111667A1/en not_active Abandoned
- 2001-11-01 AT AT01992638T patent/ATE485936T1/en not_active IP Right Cessation
-
2004
- 2004-06-02 US US10/858,589 patent/US20040220659A1/en not_active Abandoned
Patent Citations (82)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US1978A (en) * | 1841-02-13 | Manner of constructing- stoves | ||
US3407249A (en) * | 1966-01-25 | 1968-10-22 | American Cyanamid Co | Porous, extensively fibrillated polytetrafluoroethylene and method of preparing same |
US4196070A (en) * | 1977-12-12 | 1980-04-01 | Nuclepore Corporation | Method for forming microporous fluorocarbon polymer sheet and product |
US4289600A (en) * | 1978-03-31 | 1981-09-15 | Hooker Chemicals & Plastics Corp. | Microporous membrane materials |
US4304010A (en) * | 1978-10-12 | 1981-12-08 | Sumitomo Electric Industries, Ltd. | Tubular polytetrafluoroethylene prosthesis with porous elastomer coating |
US4321711A (en) * | 1978-10-18 | 1982-03-30 | Sumitomo Electric Industries, Ltd. | Vascular prosthesis |
US4576608A (en) * | 1980-11-06 | 1986-03-18 | Homsy Charles A | Porous body-implantable polytetrafluoroethylene |
US4533369A (en) * | 1982-05-28 | 1985-08-06 | Sumitomo Electric Industries, Ltd. | Gas-permselective composite membranes and process for the production thereof |
US4834746A (en) * | 1983-06-06 | 1989-05-30 | Kanegafuchi Kagaku Kogyo Kabushiki Kaisha | Artificial vessel and process for preparing the same |
US4657544A (en) * | 1984-04-18 | 1987-04-14 | Cordis Corporation | Cardiovascular graft and method of forming same |
US4605406A (en) * | 1984-08-03 | 1986-08-12 | Medtronic, Inc. | Method for fabricating prosthesis material |
US4828772A (en) * | 1984-10-09 | 1989-05-09 | Millipore Corporation | Microporous membranes of ultrahigh molecular weight polyethylene |
US5198162A (en) * | 1984-12-19 | 1993-03-30 | Scimat Limited | Microporous films |
US4725273A (en) * | 1985-08-23 | 1988-02-16 | Kanegafuchi Kagaku Kogyo Kabushiki Kaisha | Artificial vessel having excellent patency |
US4764560A (en) * | 1985-11-13 | 1988-08-16 | General Electric Company | Interpenetrating polymeric network comprising polytetrafluoroethylene and polysiloxane |
US4822361A (en) * | 1985-12-24 | 1989-04-18 | Sumitomo Electric Industries, Ltd. | Tubular prosthesis having a composite structure |
US5066683A (en) * | 1987-01-05 | 1991-11-19 | Tetratec Corporation | Microporous waterproof and moisture vapor permeable structures, processes of manufacture and useful articles thereof |
US4945125A (en) * | 1987-01-05 | 1990-07-31 | Tetratec Corporation | Process of producing a fibrillated semi-interpenetrating polymer network of polytetrafluoroethylene and silicone elastomer and shaped products thereof |
US5157058A (en) * | 1987-01-05 | 1992-10-20 | Tetratec Corporation | Microporous waterproof and moisture vapor permeable structures, processes of manufacture and useful articles thereof |
US4863604A (en) * | 1987-02-05 | 1989-09-05 | Parker-Hannifin Corporation | Microporous asymmetric polyfluorocarbon membranes |
US4849285A (en) * | 1987-06-01 | 1989-07-18 | Bio Med Sciences, Inc. | Composite macrostructure of ceramic and organic biomaterials |
US4986832A (en) * | 1987-09-04 | 1991-01-22 | Ube Industries, Ltd. | Artificial blood vessel and process for preparing it |
US4906377A (en) * | 1988-05-04 | 1990-03-06 | Millipore Corporation | Fluorocarbon membranes and process for making fluorocarbon membranes |
US4997603A (en) * | 1988-08-05 | 1991-03-05 | Hoechst Celanese Corp. | Process for formation of halogenated polymeric microporous membranes having improved strength properties |
US4963304A (en) * | 1988-09-26 | 1990-10-16 | The Dow Chemical Company | Process for preparing microporous membranes |
US4874568A (en) * | 1988-09-26 | 1989-10-17 | The Dow Chemical Company | Process of making a porous membrane |
US4951381A (en) * | 1988-10-03 | 1990-08-28 | Alps Electric Co., Ltd. | Method of manufacturing a magnetic head slider |
US5098625A (en) * | 1989-03-14 | 1992-03-24 | Yeu Ming Tai Chemical Industrial Co., Ltd. | Process for forming an expanded porous tetrafluoroethylene polymer |
US6022902A (en) * | 1989-10-31 | 2000-02-08 | The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration | Porous article with surface functionality and method for preparing same |
US5141522A (en) * | 1990-02-06 | 1992-08-25 | American Cyanamid Company | Composite material having absorbable and non-absorbable components for use with mammalian tissue |
US5123917A (en) * | 1990-04-27 | 1992-06-23 | Lee Peter Y | Expandable intraluminal vascular graft |
US5607464A (en) * | 1991-02-28 | 1997-03-04 | Medtronic, Inc. | Prosthetic vascular graft with a pleated structure |
US5248428A (en) * | 1991-06-28 | 1993-09-28 | Minnesota Mining And Manufacturing Company | Article for separations and purifications and method of controlling porosity therein |
US5980799A (en) * | 1992-03-13 | 1999-11-09 | Atrium Medical Corporation | Methods of making controlled porosity expanded polytetrafluoroethylene products and fabrication |
US5474824A (en) * | 1992-03-13 | 1995-12-12 | Atrium Medical Corporation | Process for expanding polytetrafluoroethylene and products produced thereby |
US5861033A (en) * | 1992-03-13 | 1999-01-19 | Atrium Medical Corporation | Method of making controlled porosity expanded polytetrafluoroethylene products and fabrication |
US5433909A (en) * | 1992-03-13 | 1995-07-18 | Atrium Medical Corporation | Method of making controlled porosity expanded polytetrafluoroethylene products |
US5840775A (en) * | 1992-06-25 | 1998-11-24 | E. I. Du Pont De Nemours And Company | Porous polytetraflouroethylene and preparation |
US5466509A (en) * | 1993-01-15 | 1995-11-14 | Impra, Inc. | Textured, porous, expanded PTFE |
US5474128A (en) * | 1993-07-02 | 1995-12-12 | Best Tool Co., Inc. | Telescoping conduits for increasing the fluid resistance of well production tubing inadvertently dropped in an oil or gas well |
US5810870A (en) * | 1993-08-18 | 1998-09-22 | W. L. Gore & Associates, Inc. | Intraluminal stent graft |
US5925075A (en) * | 1993-08-18 | 1999-07-20 | W. L. Gore & Associates, Inc. | Intraluminal stent graft |
US5700285A (en) * | 1993-08-18 | 1997-12-23 | W. L. Gore & Associates, Inc. | Intraluminal stent graft |
US5735892A (en) * | 1993-08-18 | 1998-04-07 | W. L. Gore & Associates, Inc. | Intraluminal stent graft |
US5723526A (en) * | 1993-09-08 | 1998-03-03 | Teijin Chemicals Ltd | Resin composition and molded article |
US5782904A (en) * | 1993-09-30 | 1998-07-21 | Endogad Research Pty Limited | Intraluminal graft |
US5639278A (en) * | 1993-10-21 | 1997-06-17 | Corvita Corporation | Expandable supportive bifurcated endoluminal grafts |
US5980923A (en) * | 1994-02-23 | 1999-11-09 | Bio Med Sciences, Inc. | Semi-interpenetrating polymer network scar treatment sheeting, process of manufacture and useful articles thereof |
US5693085A (en) * | 1994-04-29 | 1997-12-02 | Scimed Life Systems, Inc. | Stent with collagen |
US5716660A (en) * | 1994-08-12 | 1998-02-10 | Meadox Medicals, Inc. | Tubular polytetrafluoroethylene implantable prostheses |
US5776185A (en) * | 1994-09-27 | 1998-07-07 | Alessandro Verona | Cardiovascular graft |
US7083640B2 (en) * | 1995-03-10 | 2006-08-01 | C. R. Bard, Inc. | Covered stent with encapsulated ends |
US6004348A (en) * | 1995-03-10 | 1999-12-21 | Impra, Inc. | Endoluminal encapsulated stent and methods of manufacture and endoluminal delivery |
US5749880A (en) * | 1995-03-10 | 1998-05-12 | Impra, Inc. | Endoluminal encapsulated stent and methods of manufacture and endoluminal delivery |
US5641373A (en) * | 1995-04-17 | 1997-06-24 | Baxter International Inc. | Method of manufacturing a radially-enlargeable PTFE tape-reinforced vascular graft |
US5843173A (en) * | 1995-04-17 | 1998-12-01 | Baxter International Inc. | Radially-enlargeable PTFE tape-reinforced vascular grafts and their methods of manufacture |
US5744515A (en) * | 1995-05-26 | 1998-04-28 | Bsi Corporation | Method and implantable article for promoting endothelialization |
US6143675A (en) * | 1995-06-07 | 2000-11-07 | W. L. Gore & Associates (Uk) Ltd. | Porous composite |
US6235377B1 (en) * | 1995-09-05 | 2001-05-22 | Bio Med Sciences, Inc. | Microporous membrane with a stratified pore structure created in situ and process |
US5928280A (en) * | 1995-09-11 | 1999-07-27 | William Cook Europe A/S | Expandable endovascular stent |
US5788626A (en) * | 1995-11-21 | 1998-08-04 | Schneider (Usa) Inc | Method of making a stent-graft covered with expanded polytetrafluoroethylene |
US6053943A (en) * | 1995-12-08 | 2000-04-25 | Impra, Inc. | Endoluminal graft with integral structural support and method for making same |
US6190590B1 (en) * | 1996-02-28 | 2001-02-20 | Impra, Inc. | Apparatus and method for making flanged graft for end-to-side anastomosis |
US6015609A (en) * | 1996-04-04 | 2000-01-18 | Navartis Ag | Process for manufacture of a porous polymer from a mixture |
US6060530A (en) * | 1996-04-04 | 2000-05-09 | Novartis Ag | Process for manufacture of a porous polymer by use of a porogen |
US5843161A (en) * | 1996-06-26 | 1998-12-01 | Cordis Corporation | Endoprosthesis assembly for percutaneous deployment and method of deploying same |
US5769884A (en) * | 1996-06-27 | 1998-06-23 | Cordis Corporation | Controlled porosity endovascular implant |
US5928279A (en) * | 1996-07-03 | 1999-07-27 | Baxter International Inc. | Stented, radially expandable, tubular PTFE grafts |
US5741326A (en) * | 1996-07-15 | 1998-04-21 | Cordis Corporation | Low profile thermally set wrapped cover for a percutaneously deployed stent |
US5948191A (en) * | 1996-07-15 | 1999-09-07 | Cordis Corporation | Low profile, thermally set wrapped cover for a percutaneously deployed stent |
US5824046A (en) * | 1996-09-27 | 1998-10-20 | Scimed Life Systems, Inc. | Covered stent |
US6010529A (en) * | 1996-12-03 | 2000-01-04 | Atrium Medical Corporation | Expandable shielded vessel support |
US5925074A (en) * | 1996-12-03 | 1999-07-20 | Atrium Medical Corporation | Vascular endoprosthesis and method |
US6293969B1 (en) * | 1997-01-29 | 2001-09-25 | Endovascular Technologies, Inc. | Bell-bottom modular stent-graft |
US6702965B2 (en) * | 1997-02-06 | 2004-03-09 | Bollore | Method of forming a porous composite product, in particular with a high specific surface |
US5837752A (en) * | 1997-07-17 | 1998-11-17 | Massachusetts Institute Of Technology | Semi-interpenetrating polymer networks |
US6361559B1 (en) * | 1998-06-10 | 2002-03-26 | Converge Medical, Inc. | Thermal securing anastomosis systems |
US6156064A (en) * | 1998-08-14 | 2000-12-05 | Schneider (Usa) Inc | Stent-graft-membrane and method of making the same |
US6245099B1 (en) * | 1998-09-30 | 2001-06-12 | Impra, Inc. | Selective adherence of stent-graft coverings, mandrel and method of making stent-graft device |
US6540780B1 (en) * | 1998-11-23 | 2003-04-01 | Medtronic, Inc. | Porous synthetic vascular grafts with oriented ingrowth channels |
US6770202B1 (en) * | 1999-04-14 | 2004-08-03 | Pall Corporation | Porous membrane |
US20020111667A1 (en) * | 2000-11-02 | 2002-08-15 | Scimed Life Systems, Inc. | Non-expanded porous polytetrafluoroethylene (PTFE) products and methods of manufacture |
Cited By (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20020111667A1 (en) * | 2000-11-02 | 2002-08-15 | Scimed Life Systems, Inc. | Non-expanded porous polytetrafluoroethylene (PTFE) products and methods of manufacture |
US8303643B2 (en) | 2001-06-27 | 2012-11-06 | Remon Medical Technologies Ltd. | Method and device for electrochemical formation of therapeutic species in vivo |
US8840660B2 (en) | 2006-01-05 | 2014-09-23 | Boston Scientific Scimed, Inc. | Bioerodible endoprostheses and methods of making the same |
US8089029B2 (en) | 2006-02-01 | 2012-01-03 | Boston Scientific Scimed, Inc. | Bioabsorbable metal medical device and method of manufacture |
US8048150B2 (en) | 2006-04-12 | 2011-11-01 | Boston Scientific Scimed, Inc. | Endoprosthesis having a fiber meshwork disposed thereon |
US8052743B2 (en) | 2006-08-02 | 2011-11-08 | Boston Scientific Scimed, Inc. | Endoprosthesis with three-dimensional disintegration control |
US8052744B2 (en) | 2006-09-15 | 2011-11-08 | Boston Scientific Scimed, Inc. | Medical devices and methods of making the same |
US8057534B2 (en) | 2006-09-15 | 2011-11-15 | Boston Scientific Scimed, Inc. | Bioerodible endoprostheses and methods of making the same |
US8128689B2 (en) | 2006-09-15 | 2012-03-06 | Boston Scientific Scimed, Inc. | Bioerodible endoprosthesis with biostable inorganic layers |
US7955382B2 (en) | 2006-09-15 | 2011-06-07 | Boston Scientific Scimed, Inc. | Endoprosthesis with adjustable surface features |
US8808726B2 (en) | 2006-09-15 | 2014-08-19 | Boston Scientific Scimed. Inc. | Bioerodible endoprostheses and methods of making the same |
US8002821B2 (en) | 2006-09-18 | 2011-08-23 | Boston Scientific Scimed, Inc. | Bioerodible metallic ENDOPROSTHESES |
US8715339B2 (en) | 2006-12-28 | 2014-05-06 | Boston Scientific Scimed, Inc. | Bioerodible endoprostheses and methods of making the same |
US8080055B2 (en) | 2006-12-28 | 2011-12-20 | Boston Scientific Scimed, Inc. | Bioerodible endoprostheses and methods of making the same |
US8052745B2 (en) | 2007-09-13 | 2011-11-08 | Boston Scientific Scimed, Inc. | Endoprosthesis |
US7998192B2 (en) | 2008-05-09 | 2011-08-16 | Boston Scientific Scimed, Inc. | Endoprostheses |
US8236046B2 (en) | 2008-06-10 | 2012-08-07 | Boston Scientific Scimed, Inc. | Bioerodible endoprosthesis |
US7985252B2 (en) | 2008-07-30 | 2011-07-26 | Boston Scientific Scimed, Inc. | Bioerodible endoprosthesis |
US8382824B2 (en) | 2008-10-03 | 2013-02-26 | Boston Scientific Scimed, Inc. | Medical implant having NANO-crystal grains with barrier layers of metal nitrides or fluorides |
US8267992B2 (en) | 2009-03-02 | 2012-09-18 | Boston Scientific Scimed, Inc. | Self-buffering medical implants |
US8668732B2 (en) | 2010-03-23 | 2014-03-11 | Boston Scientific Scimed, Inc. | Surface treated bioerodible metal endoprostheses |
Also Published As
Publication number | Publication date |
---|---|
ATE485936T1 (en) | 2010-11-15 |
DE60143364D1 (en) | 2010-12-09 |
AU2002225830A1 (en) | 2002-05-15 |
EP1385691A2 (en) | 2004-02-04 |
US20020111667A1 (en) | 2002-08-15 |
WO2002036332A2 (en) | 2002-05-10 |
US6770086B1 (en) | 2004-08-03 |
EP1385691B1 (en) | 2010-10-27 |
WO2002036332A3 (en) | 2002-09-12 |
JP3853734B2 (en) | 2006-12-06 |
JP2004512876A (en) | 2004-04-30 |
EP2275248A1 (en) | 2011-01-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6770086B1 (en) | Stent covering formed of porous polytetraflouroethylene | |
JP3927545B2 (en) | Tubular PTFE graft with radially expandable stent | |
US6652570B2 (en) | Composite vascular graft | |
EP1041941B1 (en) | Supported graft | |
EP1164972B1 (en) | Polymer coated stent | |
EP0934034B1 (en) | Improved covered stent | |
EP0814729B1 (en) | Endoluminal encapsulated stent and methods of manufacture | |
EP1207815B1 (en) | Tubular stent-graft composite device and method of manufacture | |
US20020111668A1 (en) | Seamless braided or spun stent cover | |
JP2003534027A (en) | Intravascular stent device coated with a thin polymer | |
CA2322639C (en) | Improved ptfe vascular prosthesis and method of manufacture | |
CA2429619C (en) | Composite tubular prostheses | |
EP1767169B1 (en) | Tubular stent-graft composite device and method of manufacture |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: BOSTON SCIENTIFIC SCIMED, INC., MINNESOTA Free format text: CHANGE OF NAME;ASSIGNOR:SCIMED LIFE SYSTEMS, INC.;REEL/FRAME:018505/0868 Effective date: 20050101 Owner name: BOSTON SCIENTIFIC SCIMED, INC.,MINNESOTA Free format text: CHANGE OF NAME;ASSIGNOR:SCIMED LIFE SYSTEMS, INC.;REEL/FRAME:018505/0868 Effective date: 20050101 |
|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- AFTER EXAMINER'S ANSWER OR BOARD OF APPEALS DECISION |